GMMMG logo

NHS photos

NHS logo


<< Back

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website during Apr 2018

April 2018 



Under the GM Model Framework for dermatology services the following three documents are now available for comments.

  • 2WW Skin MK Revisions
  • Emollient Ladder
  • Steroid Ladder

Please see the Consultations page for full details and links


Please note that the consultation period for the GM Model Framework for dermatology services (mentioned below) has been extended to 5pm on Wednesday 30th May 2018)


Under direction of the GM Directors of Commissioning  the GM Dermatology Group are developing the GM Model Framework for dermatology services. The group has produced a series of educational tools which will help to improve confidence of managing skin in primary care and upskill clinicians in primary care at the same time.

Included in the educational pack is:

  • A GM pathway of care from primary care to tertiary care
  • Acne management
  • Eczema management
  • Psoriasis management
  • Warts management
  • Actinic Keratosis management
  • Refreshed skin chapter
  • 2WW pathway
  • Emollient and steroid ladders

A number of these are now opened for GM wide consultation in line with the GMMMG approval process. Please see our Consultations page for further information and details on how to submit your comments. The consultation will close at 5pm on Wednesday 30th May 2018.

Industry are invited to comment on factual inaccuracy only.

Formulary and Managed Entry Subgroup (FMESG)


The following actions were proposed at the March 2018 FMESG meeting, approved in principle by GMMMG in April, and are now open for GM wide consultation. Comments are invited up until 5pm Tuesday 15th May 2018 and should be submitted here. [Links removed - consultation closed]


The Greater Manchester DNP and grey lists have been revised to reflect recent NHS England guidance. Please note that the list contains items previously considered by GMMMG and not included in the NHS England list. Changes to these items are purely editorial, in order to harmonise wording throughout. The list also contains three new items to be considered for inclusion.

The revised list is now open for GM-wide consultation for 6 weeks. Industry are invited to comment on factual inaccuracies only. Following consultation the list will be taken forward to AGG for policy development. Comments are invited up until 5pm on Tuesday 22nd May 2018 and should be submitted here.

Pathways and Guidelines Development Subgroup (PaGDSG)


On behalf of the GMMMG Pathways and Guidelines Development Subgroup, Greater Manchester wide Shared Care Protocols for

  • Disulfiram for alcohol dependence
  • Domperidone for paediatric gastro-oesophageal reflux disease
  • Sulfasalazine for inflammatory bowel disease
  • Ciclosporin for childhood nephrotic syndrome

have been developed and we now seek the comments of all GM NHS healthcare professionals on these drafts. The consultation period is open until 5pm on 18th May 2018. Please see our consultation page [Link removed - consultation closed] for links to the documents and feedback forms

<< Back



RSS Feed